Catalyst Clinical Research LLC, a WCG company, is a specialized clinical research organization (CRO) dedicated to providing expert services for pharmaceutical, biotechnology, and medical device companies. They focus on delivering high-quality, flexible, and tailored solutions across various therapeutic areas, particularly oncology, rheumatology, and rare diseases. Catalyst offers a comprehensive suite of services including clinical trial management, site management, biostatistics, data management, regulatory affairs, and medical writing. Their approach emphasizes partnership, scientific expertise, and a commitment to accelerating the development of new therapies to improve patient lives. As part of WCG, Catalyst leverages broader capabilities and infrastructure to enhance its service offerings.
Serves as a primary center for Catalyst's clinical operations, project management, and client engagement, coordinating trials and providing specialized CRO services.
Modern office facility designed to support collaborative research activities and house specialized teams. Specific architectural details are proprietary.
The work culture at Catalyst's Wilmington office, reflecting its role as a WCG company, emphasizes scientific rigor, collaboration, patient-centricity, and a commitment to quality in clinical research. Employees often highlight a supportive team environment and opportunities for professional growth in a dynamic industry.
Wilmington's strategic location provides access to a skilled talent pool in the life sciences sector and proximity to numerous research sites and pharmaceutical partners, facilitating efficient clinical trial management.
As a WCG company, Catalyst Clinical Research leverages WCG's extensive global infrastructure to support clinical trials worldwide. Its services, including clinical trial management, site monitoring, data management, biostatistics, and regulatory affairs, are delivered across North America, Europe, and the Asia-Pacific region. This global reach enables Catalyst to manage complex, multi-national studies and provide localized expertise to meet diverse regulatory requirements and patient populations.
2521 Schieffelin Rd, Suite 100
Wilmington
NC
USA
Address: WCG, Business Garden, Żwirki i Wigury 18A, 02-092 Warszawa, Poland
Facilitates clinical research activities, site engagement, and regulatory compliance for studies conducted across the European region, leveraging WCG's established infrastructure.
Address: Leverages WCG's presence in the Research Triangle Park area for expanded operational capabilities.
Enhances Catalyst's service delivery capacity for North American clients, particularly for complex studies requiring specialized local expertise.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Catalyst Clinical Research' leadership includes:
Catalyst Clinical Research has been backed by several prominent investors over the years, including:
In the past 12 months, there have been no high-profile publicly announced executive hires or departures specifically within WCG's CRO division (Catalyst Clinical Research). WCG, the parent company, experienced a major ownership change with Cinven's acquisition in early 2024. Overall leadership for CRO services under Nick Dyer appears stable.
Discover the tools Catalyst Clinical Research uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
As Catalyst Clinical Research is a WCG company, employees typically use email addresses associated with the WCG domain (`@wcgclinical.com`). Common formats observed for WCG include first initial followed by last name, or first name separated by a dot from the last name.
[first_initial][last]@wcgclinical.com
Format
ndyer@wcgclinical.com
Example
85%
Success rate
WCG Press Release • November 29, 2023
International private equity firm Cinven announced an agreement to acquire WCG from its existing shareholders. The acquisition aims to accelerate WCG's growth and expand its technology-enabled solutions for clinical research, which includes Catalyst's CRO services. The deal was completed in early 2024....more
WCG Press Release / Clinical Leader • May 10, 2023
WCG announced it has been recognized with multiple 2023 CRO Leadership Awards by Clinical Leader and Life Science Leader magazine. These awards highlight WCG's excellence in capabilities, compatibility, expertise, quality, and reliability, underscoring the strengths of its CRO services, including those offered through Catalyst Clinical Research....more
WCG Clinical Press Release • April 25, 2023
WCG announced the launch of its new Global Site Network and expanded Patient Recruitment Services, designed to streamline study start-up and enrollment. These enhancements benefit CRO services like those provided by Catalyst by improving access to diverse patient populations and high-performing research sites....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Catalyst Clinical Research, are just a search away.